Conclusion
T1D, diabetes
HYPOGLYCEMIA, DIABETES
This RCT highlights that isCGM 2.0 is appealing and engages families and children with T1D and elevated HbA1c, as shown by the increased glucose monitoring behavior, and reduced time in hypoglycemia. However, in this study, the use of isCGM (Libre 2.0) did not translate into reducing HbA1c compared with usual care SMBG over a 12-week period. Ongoing efforts to find solutions that improve outcomes both glycemic and psychosocial are required in children experiencing the greatest difficulties and burdens with their diabetes.